about
Cystic Fibrosis: Lessons from the Sweat GlandVitamin K supplementation for cystic fibrosisInterventions for managing advanced liver disease in cystic fibrosisAtaluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisVitamin K supplementation for cystic fibrosisNebulized and oral thiol derivatives for pulmonary disease in cystic fibrosisVitamin K supplementation for cystic fibrosisVitamin K supplementation for cystic fibrosisNebulized and oral thiol derivatives for pulmonary disease in cystic fibrosisSelf-management education for cystic fibrosisCystic fibrosisEpithelial Sodium and Chloride Channels and AsthmaReactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseasesAn official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancyAspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapyApoptosis and the airway epitheliumLung transplantation for cystic fibrosisBackground and EpidemiologyAugmentation of CFTR maturation by S-nitrosoglutathione reductase.S-Nitrosothiols increases cystic fibrosis transmembrane regulator expression and maturation in the cell surface.A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis.Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigsSmall molecule correctors of F508del-CFTR discovered by structure-based virtual screeningA new scoring system in Cystic Fibrosis: statistical tools for database analysis - a preliminary report.Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceGenetic variation and clinical heterogeneity in cystic fibrosisThe piglet as a model for B cell and immune system development.Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.Airway mucus function and dysfunction.Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial culturesAntibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiCystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data.Translating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity.Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosisEstrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening.
P2860
Q22306467-A1F8E958-7BBD-4C90-AD84-B6D123E5EC33Q24186592-EECA5C09-4AA2-4279-A1B4-070C881CECEEQ24186697-F759CA5A-1126-4ACA-ACDA-9FD639E521EFQ24186760-03B56989-EEF1-4B55-B083-D810B2CA160FQ24197634-79D4C743-4FA9-4B36-A3F8-B3B5C8641A50Q24201222-BC9695BB-711E-4567-8785-9E7ADE9FC503Q24234866-7B4F830E-E047-45B5-868E-21C6AC95A0E8Q24236156-E7B1713E-C360-4C3C-98CB-687CB3158252Q24241156-1166E818-BC84-475C-AF95-A8A0523D650FQ24242757-AAFB0266-AFE0-4663-A659-9F59CCEB4BEBQ24680357-13A585DE-EB8C-4DD4-9B76-D05D895C0B9AQ26799074-41530205-D988-4C9D-9098-E90C481124A0Q26823282-069639D2-75DB-45C1-BA19-A26BA53EA68BQ26824718-446BA34D-57E0-4214-A657-A187BA136884Q28074671-284B5EA2-D203-489B-B3A7-0E3807266F54Q28741414-04DF5BF7-9EAF-46EA-94C3-332809B62D9DQ28749501-11638D28-8BB1-4190-A9B0-DE4E43E702D5Q30248742-8F45A529-971E-4A6F-9DF6-C17665628991Q30277961-D4D55ACE-4C5E-48CE-A737-F327103F7063Q30408475-A2616DB6-7C2E-492E-8BEE-73DA3DA9AEB1Q30410677-612800D1-F648-46E4-99CB-BA1FFC1915B0Q30572016-40A27851-26FF-4191-A9AD-02BF58E18EC2Q30577535-54868665-D86D-429E-8E71-F664C3AF0789Q33373854-B217B5D5-3F55-43A7-B7EF-934226833BE1Q33413056-578A114B-B1D2-4062-B912-B045B754A22BQ33608587-1091E91C-91BF-4BC0-817C-BDEFF09E65CEQ33645546-48759F3B-664E-4EA7-ABE2-2D9D4B5339FFQ33687288-67415900-A513-4A6C-887E-90CE0EAEFC05Q33703755-AD806CBA-2267-44FC-A4D4-2D36AAC871D6Q33723578-34445A0F-EE77-4F20-96AA-CA86DD7EDBDCQ33728190-96F79BE1-346B-4F6E-A236-ECF07D4C6AC6Q33792765-E79ECF36-3C93-40B7-9570-38A45FD960F3Q33810485-D4C83F6E-CC9F-498F-8EBE-E6E6C5E2F57FQ33839732-37E5B6BE-C6EB-4FB0-BE9E-69A78B95037DQ33871218-85B385CE-869E-4A81-92AB-4EFC34955AE7Q34149948-DBB664DF-4738-4BDA-8C08-F4BF0E096611Q34155281-32D4E169-23BB-43AA-B241-587C217E5F84Q34179764-1E4FCB8F-1143-474E-9647-7473F1E685CAQ34426614-E4824A4E-B0C9-4326-952C-B0FA8E7744E9Q34430936-A2566156-90D0-4219-BB6A-C8115E241D47
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cystic fibrosis since 1938.
@ast
Cystic fibrosis since 1938.
@en
type
label
Cystic fibrosis since 1938.
@ast
Cystic fibrosis since 1938.
@en
prefLabel
Cystic fibrosis since 1938.
@ast
Cystic fibrosis since 1938.
@en
P1476
Cystic fibrosis since 1938.
@en
P2093
Pamela B Davis
P304
P356
10.1164/RCCM.200505-840OE
P407
P577
2005-08-26T00:00:00Z